Clinical PharmacologyPhase Ib trialsHealthy participant studiesPharmacokineticsPharmacodynamicsDose selectionBiomarkersHybrid Ph 1a/1b design Article 24 March 2026 Phase 1b studies. Speed vs. success: What should small biotechs weigh up before moving to patients? Download PDF Share Share Share on Facebook Share on Linkedin Share on Twitter Share on Threads Share via Email Copy link to clipboard